Raffa Wealth Management’s AtriCure ATRC Stock Holding History

Raffa Wealth Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12	Closed	-$539	–	894
2020 Q2	$539	Buy	+12	New	+$522	﹤0.01%	797

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raffa Wealth Management's ATRC Position: Q3 2020 in Review

Raffa Wealth Management sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 12 shares — an estimated $539 sold.

Raffa Wealth Management first reported a position in ATRC in Q2 2020 and held it in 1 quarter. The position peaked at $539 in Q2 2020. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.

Raffa Wealth Management reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
Raffa Wealth Management sold 12 AtriCure shares in Q3 2020, an estimated $539.
Raffa Wealth Management first reported a position in AtriCure in Q2 2020 and held it in 1 quarter.
Raffa Wealth Management's AtriCure position peaked at $539 in Q2 2020.
183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.

Based on Raffa Wealth Management's 13F filing for Q3 2020, filed 27 Jul 2026.